EdgarLookup

Moore Paul Andrew

Insider transactions at 1 company

This page shows all SEC Form 4 filings attributed to Moore Paul Andrew. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

ZYME
Company Title Type Shares Price Value Date
ZYME Chief Scientific Officer Option Exercise 17,166 — — Jan 6, 2025
ZYME Chief Scientific Officer Sale 7,460 $10.65 $79,449 Jan 8, 2024